Presented for research literature review only Zawilska JB et al
Pure tides therapy is not a compounding pharmacy or compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor is it an outsourcing facility as defined under Section 503B of the same Act
Intradermal injections of a hair growth factor formulation for enhancement of human hair regrowth: safety and efficacy evaluation in a first-in-man pilot clinical study
The prevailing sentiment is that the two are complementary, and the Wolverine Stack pairing is discussed more often than an either/or decision
GLP-1 Medications and Mast Cell Activation MCAS is common in the EDS community
Given the pronounced effect of tau elimination observed in in vitro and in vivo studies, selecting patients who test positive for tau biomarkers (CSF, blood, or positron emission tomography) could enhance the likelihood of achieving significant disease modification
